XML 46 R57.htm IDEA: XBRL DOCUMENT
v2.4.1.9

Quarterly Financial Summary (Unaudited) (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2014
Quarterly Financial Information Disclosure [Abstract] |
Quarterly Financial Summary |
| First Quarter |  | Second Quarter |  | Third Quarter |  | Fourth Quarter
| (In thousands, except per share amounts)
2014 |  |  |  |  |  |  |
Net sales | $ | 599,843 |  |  | $ | 604,721 |  |  | $ | 642,418 |  |  | $ | 598,566 |
Gross profit | $ | 195,599 |  |  | $ | 207,363 |  |  | $ | 205,446 |  |  | $ | 162,440 |
Restructuring and other charges, net(a) | $ | 17,000 |  |  | $ | 3,332 |  |  | $ | 293 |  |  | $ | 5,322 |
Acquisition and integration related costs(b) | $ | — |  |  | $ | 4,843 |  |  | $ | 10,261 |  |  | $ | 15,054 |
Net income (loss) from continuing operations | $ | 66,004 |  |  | $ | 89,404 |  |  | $ | 88,019 |  |  | $ | (12,990 | )
Loss from discontinued operations (net of tax)(c) | (1,769 | ) |  | (60,025 | ) |  | (6,679 | ) |  | (1,058 | )
Net income attributable to noncontrolling interests | (7,652 | ) |  | (6,932 | ) |  | (8,546 | ) |  | (4,460 | )
Net income (loss) attributable to Albemarle Corporation | $ | 56,583 |  |  | $ | 22,447 |  |  | $ | 72,794 |  |  | $ | (18,508 | )
Basic earnings (loss) per share: |  |  |  |  |  |  |
Continuing operations | $ | 0.73 |  |  | $ | 1.05 |  |  | $ | 1.02 |  |  | $ | (0.22 | )
Discontinued operations | (0.02 | ) |  | (0.76 | ) |  | (0.09 | ) |  | (0.02 | )
| $ | 0.71 |  |  | $ | 0.29 |  |  | $ | 0.93 |  |  | $ | (0.24 | )
Shares used to compute basic earnings per share | 79,735 |  |  | 78,662 |  |  | 78,244 |  |  | 78,144 |
Diluted earnings (loss) per share: |  |  |  |  |  |  |
Continuing operations | $ | 0.73 |  |  | $ | 1.04 |  |  | $ | 1.01 |  |  | $ | (0.22 | )
Discontinued operations | (0.02 | ) |  | (0.76 | ) |  | (0.08 | ) |  | (0.02 | )
| $ | 0.71 |  |  | $ | 0.28 |  |  | $ | 0.93 |  |  | $ | (0.24 | )
Shares used to compute diluted earnings per share | 80,112 |  |  | 79,091 |  |  | 78,659 |  |  | 78,545 |
| First Quarter |  | Second Quarter |  | Third Quarter |  | Fourth Quarter
| (In thousands, except per share amounts)
2013 |  |  |  |  |  |  |
Net sales | $ | 586,597 |  |  | $ | 576,842 |  |  | $ | 591,196 |  |  | $ | 639,635 |
Gross profit | $ | 195,911 |  |  | $ | 191,670 |  |  | $ | 209,611 |  |  | $ | 253,279 |
Restructuring and other charges, net(a) | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 33,361 |
Net income from continuing operations | $ | 87,681 |  |  | $ | 88,500 |  |  | $ | 97,313 |  |  | $ | 162,232 |
Income (loss) from discontinued operations (net of tax) | 1,835 |  |  | 2,628 |  |  | 531 |  |  | (886 | )
Net income attributable to noncontrolling interests | (5,529 | ) |  | (8,389 | ) |  | (7,332 | ) |  | (5,413 | )
Net income attributable to Albemarle Corporation | $ | 83,987 |  |  | $ | 82,739 |  |  | $ | 90,512 |  |  | $ | 155,933 |
Basic earnings (loss) per share: |  |  |  |  |  |  |
Continuing operations | $ | 0.93 |  |  | $ | 0.95 |  |  | $ | 1.10 |  |  | $ | 1.93 |
Discontinued operations | 0.02 |  |  | 0.03 |  |  | 0.01 |  |  | (0.01 | )
| $ | 0.95 |  |  | $ | 0.98 |  |  | $ | 1.11 |  |  | $ | 1.92 |
Shares used to compute basic earnings per share | 88,719 |  |  | 84,028 |  |  | 81,385 |  |  | 81,226 |
Diluted earnings (loss) per share: |  |  |  |  |  |  |
Continuing operations | $ | 0.92 |  |  | $ | 0.95 |  |  | $ | 1.10 |  |  | $ | 1.92 |
Discontinued operations | 0.02 |  |  | 0.03 |  |  | 0.01 |  |  | (0.01 | )
| $ | 0.94 |  |  | $ | 0.98 |  |  | $ | 1.11 |  |  | $ | 1.91 |
Shares used to compute diluted earnings per share | 89,236 |  |  | 84,489 |  |  | 81,852 |  |  | 81,713 |
(a) | See Note 20, “Restructuring and Other.”
(b) | See Note 23, “Acquisitions.”
(c) | Included in Loss from discontinued operations (net of tax) for the year ended December 31, 2014 is $(65.7) million related to the loss on the sale of our antioxidant, ibuprofen and propofol businesses and assets, the majority of which was recorded in the second quarter. See Note 2, “Discontinued Operations.”

X
- Details
Name: | us-gaap_QuarterlyFinancialInformationDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the quarterly financial data in the annual financial statements. The disclosure includes financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income (loss) before extraordinary items and cumulative effect of a change in accounting principle and earnings per share data. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a)-(j) -URI http://asc.fasb.org/extlink&oid=35737889&loc=d3e1280-108306 + Details
Name: | us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration